|

Phase II Trial of Immunonutrition in Hepatectomy

RECRUITINGN/ASponsored by Tata Memorial Centre
Actively Recruiting
PhaseN/A
SponsorTata Memorial Centre
Started2025-10-03
Est. completion2027-10-31
Eligibility
Age18 Years – 90 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07395635

Summary

A randomised open labelled study to evalaute the impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors

Eligibility

Age: 18 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Patients with liver tumors planned for major hepatectomies (defined as resection of \>/= 3 liver segments)
2. Age above 18 years
3. ASA class I-III

Exclusion Criteria:

1. Preoperative severe renal failure (estimated glomerular filtration rate \< 30 ml/min)
2. History of hypersensitivity to arginine, omega-3 fatty acids, or nucleotide 3. Inability to take oral nutrition

4\. Pregnancy 5. Mental condition rendering the subject unable to understand the nature, endpoints and consequences of the trial

Conditions5

ASA I-III PatientsCancerHepatocellular CarcinomaLiver CancerLiver Disease

Browse More Trials

Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.